Skip to main content
. 2020 Dec 14;2020:6661642. doi: 10.1155/2020/6661642

Figure 2.

Figure 2

Repeated WY-14643 administration alleviated NP in CCI rats by activating PPARα. (a) WY-14643 increased the PWMT of CCI rats, but GW6471 and si-SIRT1 reversed this effect. (b) WY-14643 increased the PWTL of CCI rats, but GW6471 and si-SIRT1 reversed this effect.